Dementia Drugs
Dementia drugs, particularly for Alzheimer's Disease, focus on symptom management rather than cure. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine enhance brain function by boosting acetylcholine levels, crucial for memory and learning. Another medication, memantine, an NMDA receptor antagonist, helps regulate glutamate activity, addressing symptoms such as confusion and memory loss. While these drugs can temporarily improve cognitive function and quality of life, they do not stop the progression of the disease. Ongoing research seeks to identify new therapeutic targets and more effective treatments that could potentially alter the course of dementia in the future.
Committee Members
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia